Mitochondria as a therapeutic target for common pathologies
MP Murphy, RC Hartley - Nature Reviews Drug Discovery, 2018 - nature.com
Although the development of mitochondrial therapies has largely focused on diseases
caused by mutations in mitochondrial DNA or in nuclear genes encoding mitochondrial …
caused by mutations in mitochondrial DNA or in nuclear genes encoding mitochondrial …
[HTML][HTML] Marine sponges as a drug treasure
K Anjum, SQ Abbas, SAA Shah, N Akhter… - Biomolecules & …, 2016 - ncbi.nlm.nih.gov
Marine sponges have been considered as a drug treasure house with respect to great
potential regarding their secondary metabolites. Most of the studies have been conducted …
potential regarding their secondary metabolites. Most of the studies have been conducted …
The essentials of marine biotechnology
Coastal countries have traditionally relied on the existing marine resources (eg, fishing,
food, transport, recreation, and tourism) as well as tried to support new economic endeavors …
food, transport, recreation, and tourism) as well as tried to support new economic endeavors …
IL-6 translation is a therapeutic target of human cytokine release syndrome
Y Yang, Y Zhang, X Xing, G Xu, X Lin, Y Wang… - Journal of Experimental …, 2023 - rupress.org
Chimeric antigen receptor (CAR) T therapies have achieved remarkable success for treating
hematologic malignancies, yet are often accompanied by severe cytokine release syndrome …
hematologic malignancies, yet are often accompanied by severe cytokine release syndrome …
The use of β-blockers in heart failure with reduced ejection fraction
D Masarone, ML Martucci, V Errigo… - Journal of cardiovascular …, 2021 - mdpi.com
Treatment with β-blockers is the main strategy for managing patients with heart failure and
reduced ejection fraction because of their ability to reverse the neurohumoral effects of the …
reduced ejection fraction because of their ability to reverse the neurohumoral effects of the …
β-Adrenergic receptor, an essential target in cardiovascular diseases
Abstract β-Adrenergic receptors (βARs) belong to a large family of cell surface receptors
known as G protein–coupled receptors (GPCRs). They are coupled to Gs protein (Gαs) for …
known as G protein–coupled receptors (GPCRs). They are coupled to Gs protein (Gαs) for …
Cancer cells become less deformable and more invasive with activation of β-adrenergic signaling
Invasion by cancer cells is a crucial step in metastasis. An oversimplified view in the
literature is that cancer cells become more deformable as they become more invasive. β …
literature is that cancer cells become more deformable as they become more invasive. β …
Use of β-blockers in pulmonary hypertension
F Perros, FS De Man, HJ Bogaard, F Antigny… - Circulation: Heart …, 2017 - Am Heart Assoc
Contrasting with the major attention that left heart failure has received, right heart failure
remains understudied both at the preclinical and clinical levels. However, right ventricle …
remains understudied both at the preclinical and clinical levels. However, right ventricle …
Therapeutic potential of targeting ß-arrestin
ß-arrestins are multifunctional proteins that modulate heptahelical 7 transmembrane
receptors, also known as G protein-coupled receptors (GPCRs), a superfamily of receptors …
receptors, also known as G protein-coupled receptors (GPCRs), a superfamily of receptors …
Allergic asthma is a risk factor for human cardiovascular diseases
Asthma is an allergic airway disease in which type 2-mediated inflammation has a
pathogenic role. Cardiovascular diseases (CVDs) are type 1-dominant inflammatory …
pathogenic role. Cardiovascular diseases (CVDs) are type 1-dominant inflammatory …